The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
Growth was broad-based across segments
The ETHICON 4000 Stapler and ETHICON 3D Reloads are now approved for use in both open and laparoscopic surgeries across the European Union
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Targets high-growth eye care expansion push
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
Subscribe To Our Newsletter & Stay Updated
